Remdesivir inhibits the coronavirus RNA dependent RNA polymerase RdRp #180136611
Description
The nucleotide analog remdesivir blocks the SARS-CoV-2 RNA dependent RNA polymerase and is a promising drug for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 7BTF